イリノイ州における大腸癌の臨床試験
イリノイ州内の拠点で、大腸癌に関する51件の研究が参加者を募集しています。
イリノイ州内の都市
- Chicago33件の研究
- Arlington Heights12件の研究
- Peoria12件の研究
- Evanston10件の研究
- Cicero10件の研究
- Springfield9件の研究
- North Peoria7件の研究
- Bloomington7件の研究
- Carbondale7件の研究
- Galesburg7件の研究
- Waukegan6件の研究
- Danville6件の研究
- Decatur6件の研究
- Champaign6件の研究
- Charleston5件の研究
- Elgin4件の研究
- Naperville4件の研究
- Aurora3件の研究
- Rockford3件の研究
公式研究テキスト（英語）
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- University of Illinois, Chicago
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05673148Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- Northwestern Memorial Hospital, Chicago
被験者募集中
65歳〜82歳 · 全性別 · 2026/10/02更新 · NCT05612347A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- University of Chicago Medical Center /ID# 279365, Chicago
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07525206Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- 他54件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Family Communications After Genetic Testing
- OSF Saint Anthony's Health Center, Alton
- Advocate Outpatient Center - Aurora, Aurora
- Advocate Good Shepherd Hospital, Barrington
- 他46件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #26, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Orchard Healthcare Research Inc.- Skokie, Skokie
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06324357PRE-ISPY Phase I/II Oncology Platform Program
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
- UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, New Lenox
- UChicago Medicine Orland Park, Orland Park
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT05868226A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- University of Chicago Medical Center /ID# 271688, Chicago
- Hope And Healing Cancer Services /ID# 271562, Hinsdale
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06820463Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Illinois Cancer Specialists, Arlington Heights
- Illinois CancerCare - Bloomington, Bloomington
- Illinois Cancer Specialists, Chicago
- 他10件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06218914A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
- University of Chicago, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06004245A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Illinois Cancer Specialists, Arlington Heights
- Illinois CancerCare, Peoria
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06750094Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
- City of Hope at Chicago, Zion
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07271355A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Illinois Cancer Specialists, Arlington Heights
- Illinois CancerCare, Peoria
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06662786Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Northwestern Medicine Cancer Center Old Irving Park, Chicago
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT05863195A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Local Institution - 0433, Chicago
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07221357Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
- University of Chicago, Chicago
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/21更新 · NCT06349590A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Sih Cancer Institute, Carterville
- University of Illinois Cancer Center, Chicago
- Alexian Brothers Medical Center, Elk Grove Village
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Illinois Cancer Specialists, Arlington Heights
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/11更新 · NCT04929223SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
- Orchard Healthcare Research Inc., Skokie
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/11更新 · NCT05935384A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Illinois Cancer Specialists, Arlington Heights
- Illinois CancerCare PC, Peoria
- Springfield Clinic, Springfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07549412Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
- Memorial Hospital East, Shiloh
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06696768Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Chicago
- Clinical Study Site, Elmhurst
- Clinical Study Site, O'Fallon
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07228832Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Insight Research Institute, Chicago
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06252649Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Lurie Children's Hospital-Chicago, Chicago
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Research Site, Chicago
被験者募集中第2相
18歳〜130歳 · 全性別 · 2026/08/18更新 · NCT06792695Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
- City of Hope at Chicago, Zion
被験者募集中
18歳以上 · 全性別 · 2026/08/12更新 · NCT07125729A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Orchard Healthcare Research Inc, Skokie
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06330064A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Hope and Healing Cancer Services, Hinsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
- Hope and Healing Cancer Services, Hinsdale
- Orchard Healthcare Research, Skokie
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06937177A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- University of Chicago Medical Center /ID# 274742, Chicago
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/10更新 · NCT07023289Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
- Northwestern University-Comprehensive Transplant Center, Chicago
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/10更新 · NCT06698146A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
- Hope and Healing Cancer Services, Hinsdale
被験者募集中第4相
18歳以上 · 全性別 · 2026/07/07更新 · NCT06562543A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- The University of Chicago Medical Center - Oncology, Chicago
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/02更新 · NCT07169734CT-95 in Advanced Cancers Associated With Mesothelin Expression
- Context Investigational Site, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06756035A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Illinois Cancer Specialists, Arlington Heights
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07011576BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- OSF Healthcare Cancer Institute, Peoria
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/02更新 · NCT06917079Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
被験者募集中観察研究健康なボランティア歓迎
18歳〜49歳 · 全性別 · 2026/04/24更新 · NCT05732623ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。